SEC Filing Summary

This filing, dated June 12, 2026, details a transaction by Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN). Simmons acquired 116.9603 Deferred Stock Units, with each unit representing the right to one share of the company's common stock or its cash equivalent. These units are part of an executive deferral and stock match plan and will settle in cash or shares following termination of employment or during a specified future year. The transaction occurred on June 12, 2026, with a price per unit of $24.17. Post-transaction, Simmons holds 24,541.9486 Deferred Stock Units. The filing is Form 4, indicating a change in beneficial ownership.